{
  "thread": {
    "uuid": "4ff177914ddc81e10d985379e1b671b89ecd151a",
    "url": "https://in.marketscreener.com/quote/stock/BIO-THERA-SOLUTIONS-LTD-103374480/news/Bio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136",
    "site_full": "in.marketscreener.com",
    "site": "marketscreener.com",
    "site_section": "https://in.marketscreener.com/news/companies/sectors/",
    "site_categories": [],
    "section_title": "Stock Market Listed Companies News - MarketScreener India",
    "site_title": "Stock Market Today : Reports, Quotes and News - MarketScreener",
    "title": "Bio-Thera Solutions, Inc. Announces Independent Data Monitoring Committee Recommends Early Study Termination for Pivotal Phase II/III Trial of BAT4406F in Neuromyelitis Optica Spectrum Disorder Based on Positive Interim Analysis Results | MarketScreener India",
    "title_full": "Bio-Thera Solutions, Inc. Announces Independent Data Monitoring Committee Recommends Early Study Termination for Pivotal Phase II/III Trial of BAT4406F in Neuromyelitis Optica Spectrum Disorder Based on Positive Interim Analysis Results | MarketScreener India",
    "published": "2025-07-02T16:06:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "IN",
    "main_image": "https://in.marketscreener.com/images/twitter_MS_fdnoir.png",
    "performance_score": 0,
    "domain_rank": 3601,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "4ff177914ddc81e10d985379e1b671b89ecd151a",
  "url": "https://in.marketscreener.com/quote/stock/BIO-THERA-SOLUTIONS-LTD-103374480/news/Bio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136",
  "ord_in_thread": 0,
  "author": "S&P Capital IQ",
  "published": "2025-07-02T16:06:00.000+03:00",
  "title": "Bio-Thera Solutions, Inc. Announces Independent Data Monitoring Committee Recommends Early Study Termination for Pivotal Phase II/III Trial of BAT4406F in Neuromyelitis Optica Spectrum Disorder Based on Positive Interim Analysis Results | MarketScreener India",
  "text": "Bio-Thera Solutions Inc. announced that the Independent Data Monitoring Committee (IDMC) has recommended early study termination for the pivotal Phase II/III trial of BAT4406F in neuromyelitis optica spectrum disorder (NMOSD) based on positive interim analysis results. Following this recommendation, Bio-Thera has decided to close patient enrollment ahead of schedule. BAT4406F is an ADCC-enhanced, fully humanized anti-CD20 monoclonal antibody developed by Bio-Thera.\nThe randomized, double-blind, placebo-controlled phase II/III clinical trial, led by Professor Chen Xiangjun of Huashan Hospital, Fudan University (China), is being conducted across 45 sites in China. Following a formal review of interim data, the IDMC concluded that BAT4406F demonstrated statistically significant efficacy, meeting the pre-defined superiority criteria, and recommended early trial termination due to compelling efficacy. Based on this recommendation, Bio- Thera has decided to close enrollment ahead of schedule and begin preparation to file for regulatory approval from NMPA.\nShare Â© S&P Capital IQ - 2025",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->health organisation",
    "Health->medical condition",
    "Health->health treatment and procedure",
    "Science and Technology->biomedical science",
    "Science and Technology->medical research",
    "Science and Technology->scientific research"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [
    "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dlinkedin%26utm_medium%3Dsocial%26utm_campaign%3Dshare&title=Bio-Thera",
    "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dfacebook%26utm_medium%3Dsocial%26utm_campaign%3Dshare",
    "https://x.com/intent/tweet?text=Bio-Thera",
    "https://wa.me/?text=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dwhatsapp%26utm_medium%3Dsocial%26utm_campaign%3Dshare",
    "https://telegram.me/share/url?url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dtelegram%26utm_medium%3Dsocial%26utm_campaign%3Dshare",
    "https://x.com/intent/tweet",
    "https://telegram.me/share/url",
    "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dfacebook%26utm_medium%3Dsocial%26utm_campaign%3Dshare",
    "https://linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dlinkedin%26utm_medium%3Dsocial%26utm_campaign%3Dshare&title=Bio-Thera",
    "https://wa.me/",
    "https://www.facebook.com/sharer/sharer.php",
    "https://www.linkedin.com/shareArticle",
    "https://www.wa.me/?text=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dwhatsapp%26utm_medium%3Dsocial%26utm_campaign%3Dshare",
    "https://www.x.com/intent/tweet?text=Bio-Thera",
    "https://www.telegram.me/share/url?url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FBIO-THERA-SOLUTIONS-LTD-103374480%2Fnews%2FBio-Thera-Solutions-Inc-Announces-Independent-Data-Monitoring-Committee-Recommends-Early-Study-Ter-50403136%2F%3Futm_source%3Dtelegram%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
  ],
  "entities": {
    "persons": [
      {
        "name": "Chen Xiangjun",
        "sentiment": "none"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "Announces Independent Data Monitoring Committee",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "Bio-Thera Solutions Inc.",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "Fudan University",
        "sentiment": "none",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-07-03T08:32:27.593+03:00",
  "updated": "2025-07-03T05:39:07.000+00:00"
}